Viewing Study NCT02712203

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:41 PM
Ignite Modification Date: 2026-02-23 @ 8:07 PM
Study NCT ID: NCT02712203
Status: UNKNOWN
Last Update Posted: 2016-03-18
First Post: 2016-03-14
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: MMR and MMRV Vaccines: Effect of Age at First Dose on Safety and Immunogenicity of the Measles Component.
Sponsor: CHU de Quebec-Universite Laval
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Measles View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Measles vaccine View
None Priorix View
None Priorix-Tetra View
None Age at vaccination View